Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-17
1999-11-23
Stockton, Laura L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514393, 5483021, 5483044, 5483047, A61K 31415, C07D23508
Patent
active
059901462
ABSTRACT:
Benzimidazoles of Formula I below are inhibitors of protein tyrosine kinases, and are useful in treating cellular proliferation. ##STR1## The compounds are especially useful in treating cancer, atherosclerosis, restenosis, and psoriasis.
REFERENCES:
patent: 3644382 (1972-02-01), Clemence et al.
patent: 4186135 (1980-01-01), Thominet et al.
patent: 4492708 (1985-01-01), Spitzer
patent: 5283242 (1994-02-01), Ellingboe
patent: 5360809 (1994-11-01), Axelsson et al.
patent: 5527548 (1996-06-01), Tyortyalian
patent: 5552426 (1996-09-01), Lunn et al.
patent: 5554632 (1996-09-01), Teuber et al.
Boschelli Diane Harris
Denny William Alexander
Doherty Annette Marian
Hamby James Marino
Khatana Sonya Shah
Crissey Todd M.
Stockton Laura L.
Warner-Lambert & Company
LandOfFree
Benzimidazoles for inhibiting protein tyrosine kinase mediated c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazoles for inhibiting protein tyrosine kinase mediated c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazoles for inhibiting protein tyrosine kinase mediated c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222421